FDA Accepts Reproxalap Application for Dry Eye Disease – HCPLive

… dry eyes. Aldeyra resubmitted reproxalap's NDA on October 3, 2024, including a draft label reflecting acute activity in reducing DED symptoms in a dry …

Source: google.com